Regenxbio RGNX Accounts Payable

Accounts Payable at other companies

Regeneron PharmaceuticalsREGN

$1.16B+60.1%

Sarepta Therapeutics, Inc.SRPT

$50.98M-62.7%

BiogenBIIB

$403.9M-1.1%

BioMarin PharmaceuticalsBMRN

$1.01B+47.0%

EyePoint, Inc.EYPT

$17.27M-12.3%

4D Molecular TherapeuticsFDMT

$14.69M+254%

FAQ

What is Regenxbio's accounts payable?

Regenxbio (RGNX) reported accounts payable of $15.55M in Q2 2026.

How has Regenxbio's accounts payable changed year-over-year?

Regenxbio's accounts payable decreased by 28.2% year-over-year, from $21.66M to $15.55M.

What is the long-term trend for Regenxbio's accounts payable?

Over 5 years (2020 to 2025), Regenxbio's accounts payable has grown at a 15.0% compound annual growth rate (CAGR), from $10.62M to $21.36M.

What does accounts payable mean?

Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.